Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Japanese Males
Clinical trial NCT00479297 · COMPLETED
Trial details
- NCT number
- NCT00479297
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2007-02-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.